Advertisement

Index by author

July 01, 2012; Volume 82,Issue 1

A

  1. Almazrooa, Soulafa A.

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

  2. Ambudkar, Suresh V.

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  3. Anderson, Karen S.

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

  4. Auzanneau, Céline

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

B

  1. Baba, Masanori

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

  2. Basha, Maram Talal

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

  3. Berger, Joel P.

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

  4. Berlin, Joshua R.

    1. Membrane Potential-Dependent Inhibition of the Na+,K+-ATPase by para-Nitrobenzyltriethylammonium Bromide
      R. Daniel Peluffo and Joshua R. Berlin
      Molecular Pharmacology July 2012, 82 (1) 1-8; DOI: https://doi.org/10.1124/mol.111.077008

  5. Bernhardt, Paul V.

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

  6. Boni-Mitake, Malvina

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

C

  1. Cha, Seunghee

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

  2. Chen, Xing-gui

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  3. Chen, Zhe-Sheng

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  4. Cohen-Tannoudji, Joelle

    1. Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523

  5. Copeland, William C.

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

D

  1. Dai, Hongyue

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

  2. Deffieux, Denis

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

  3. de Freitas, Jose C.

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

  4. De Giorgi, Francesca

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

  5. de Oliveira, Eduardo B.

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

  6. Diepold, Maximilian

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

E

  1. Elkaoukabi-Chaibi, Assia

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

  2. Eloranta, Jyrki J.

    1. The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor
      Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick
      Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909

  3. Errasti-Murugarren, Ekaitz

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

F

  1. Fernández-Calotti, Paula

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

  2. Fu, Li-wu

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

G

  1. Gutierrez, Elaine

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

H

  1. Hiller, Christian

    1. The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor
      Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick
      Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909

  2. Hohl, Raymond J.

    1. Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107

I

  1. Ichas, François

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

  2. Ichimonji, Isao

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

  3. Illes, Peter

    1. Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch
      Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes
      Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818

J

  1. Jacquet, Rémi

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

  2. Jansson, Patric J.

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

  3. Jin, Jun-O

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

  4. Jüttner, Moritz

    1. The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor
      Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick
      Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909

K

  1. Kajiya, Mikihito

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

  2. Kalinowski, Danuta S.

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

  3. Kasiviswanathan, Rajesh

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

  4. Kawai, Toshihisa

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

  5. Kim, Jiae

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

  6. Kim, Sang Geon

    1. Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury
      Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim
      Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149

  7. Kipp, Helmut

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

  8. Koepsell, Hermann

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

  9. Koo, Ja Hyun

    1. Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury
      Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim
      Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149

  10. Kuder, Craig H.

    1. Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107

  11. Kullak-Ublick, Gerd A.

    1. The SLCO1A2 Gene, Encoding Human Organic Anion-Transporting Polypeptide 1A2, Is Transactivated by the Vitamin D Receptor
      Jyrki J. Eloranta, Christian Hiller, Moritz Jüttner and Gerd A. Kullak-Ublick
      Molecular Pharmacology July 2012, 82 (1) 37-46; DOI: https://doi.org/10.1124/mol.112.077909

L

  1. Lanier, Stephen M.

    1. Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523

  2. Lee, Chan Gyu

    1. Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury
      Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim
      Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149

  3. Lee, Woo Hyung

    1. Fyn Inhibition by Cycloalkane-Fused 1,2-Dithiole-3-thiones Enhances Antioxidant Capacity and Protects Mitochondria from Oxidative Injury
      Ja Hyun Koo, Woo Hyung Lee, Chan Gyu Lee and Sang Geon Kim
      Molecular Pharmacology July 2012, 82 (1) 27-36; DOI: https://doi.org/10.1124/mol.111.077149

  4. Leichsenring, Anna

    1. Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch
      Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes
      Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818

  5. Liang, Yong-ju

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  6. Lovejoy, David B.

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

  7. Lum, Pek Yee

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

M

  1. Meinke, Peter T.

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

  2. Min, Christine

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

  3. Mitsuya, Hiroaki

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

  4. Montaudon, Danièle

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

  5. Muise, Eric S.

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

N

  1. Neighbors, Jeffrey D.

    1. Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107

O

  1. Oguiura, Nancy

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

  2. Oner, Sukru S.

    1. Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523

  3. Orts, Diego J. B.

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

P

  1. Pastor-Anglada, Marçal

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

  2. Peigneur, Steve

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

  3. Peluffo, R. Daniel

    1. Membrane Potential-Dependent Inhibition of the Na+,K+-ATPase by para-Nitrobenzyltriethylammonium Bromide
      R. Daniel Peluffo and Joshua R. Berlin
      Molecular Pharmacology July 2012, 82 (1) 1-8; DOI: https://doi.org/10.1124/mol.111.077008

  4. Pérez-Torras, Sandra

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

  5. Pinilla-Macua, Itziar

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

  6. Pourquier, Philippe

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

  7. Pouységu, Laurent

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

  8. Pradere, Ugo

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

  9. Prieto da Silva, Alvaro R.

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

  10. Puyo, Stéphane

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

Q

  1. Quach, Patricia

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

  2. Quideau, Stéphane

    1. The Polyphenolic Ellagitannin Vescalagin Acts As a Preferential Catalytic Inhibitor of the α Isoform of Human DNA Topoisomerase II
      Céline Auzanneau, Danièle Montaudon, Rémi Jacquet, Stéphane Puyo, Laurent Pouységu, Denis Deffieux, Assia Elkaoukabi-Chaibi, Francesca De Giorgi, François Ichas, Stéphane Quideau and Philippe Pourquier
      Molecular Pharmacology July 2012, 82 (1) 134-141; DOI: https://doi.org/10.1124/mol.111.077537

R

  1. Raubertas, Richard

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

  2. Richardson, Des R.

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

  3. Riedel, Thomas

    1. Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch
      Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes
      Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818

S

  1. Schinazi, Raymond F.

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

  2. Sharpe, Philip C.

    1. Methemoglobin Formation by Triapine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and Other Anticancer Thiosemicarbazones: Identification of Novel Thiosemicarbazones and Therapeutics That Prevent This Effect
      Patricia Quach, Elaine Gutierrez, Maram Talal Basha, Danuta S. Kalinowski, Philip C. Sharpe, David B. Lovejoy, Paul V. Bernhardt, Patric J. Jansson and Des R. Richardson
      Molecular Pharmacology July 2012, 82 (1) 105-114; DOI: https://doi.org/10.1124/mol.112.078964

  3. Sheehy, Ryan M.

    1. Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107

  4. Sim, Hong May

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  5. Simon, Violaine

    1. Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523

  6. Singh, Satyakam

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  7. Sohl, Christal D.

    1. Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase
      Christal D. Sohl, Rajesh Kasiviswanathan, Jiae Kim, Ugo Pradere, Raymond F. Schinazi, William C. Copeland, Hiroaki Mitsuya, Masanori Baba and Karen S. Anderson
      Molecular Pharmacology July 2012, 82 (1) 125-133; DOI: https://doi.org/10.1124/mol.112.078758

  8. Sun, Yueli

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

T

  1. Talele, Tanaji T.

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  2. Tan, Yejun

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

  3. Thompson, G. Marie

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

  4. Thompson, John R.

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

  5. Tikhonov, Denis B.

    1. Architecture and Pore Block of Eukaryotic Voltage-Gated Sodium Channels in View of NavAb Bacterial Sodium Channel Structure
      Denis B. Tikhonov and Boris S. Zhorov
      Molecular Pharmacology July 2012, 82 (1) 97-104; DOI: https://doi.org/10.1124/mol.112.078212

  6. Tobin, Andrew B.

    1. Influence of the Accessory Protein SET on M3 Muscarinic Receptor Phosphorylation and G Protein Coupling
      Violaine Simon, Sukru S. Oner, Joelle Cohen-Tannoudji, Andrew B. Tobin and Stephen M. Lanier
      Molecular Pharmacology July 2012, 82 (1) 17-26; DOI: https://doi.org/10.1124/mol.111.075523

  7. Tytgat, Jan

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

V

  1. Veyhl-Wichmann, Mayke

    1. Role of the Transporter Regulator Protein (RS1) in the Modulation of Concentrative Nucleoside Transporters (CNTs) in Epithelia
      Ekaitz Errasti-Murugarren, Paula Fernández-Calotti, Mayke Veyhl-Wichmann, Maximilian Diepold, Itziar Pinilla-Macua, Sandra Pérez-Torras, Helmut Kipp, Hermann Koepsell and Marçal Pastor-Anglada
      Molecular Pharmacology July 2012, 82 (1) 59-67; DOI: https://doi.org/10.1124/mol.111.076992

W

  1. Wiemer, David F.

    1. Functional Evaluation of a Fluorescent Schweinfurthin: Mechanism of Cytotoxicity and Intracellular Quantification
      Craig H. Kuder, Ryan M. Sheehy, Jeffrey D. Neighbors, David F. Wiemer and Raymond J. Hohl
      Molecular Pharmacology July 2012, 82 (1) 9-16; DOI: https://doi.org/10.1124/mol.111.077107

  2. Wiese, Sara

    1. Effects of Nucleotide Analogs at the P2X3 Receptor and Its Mutants Identify the Agonist Binding Pouch
      Thomas Riedel, Sara Wiese, Anna Leichsenring and Peter Illes
      Molecular Pharmacology July 2012, 82 (1) 80-89; DOI: https://doi.org/10.1124/mol.112.077818

  3. Wong, Kenny K.

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

  4. Wood, Harold B.

    1. Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists
      Yejun Tan, Eric S. Muise, Hongyue Dai, Richard Raubertas, Kenny K. Wong, G. Marie Thompson, Harold B. Wood, Peter T. Meinke, Pek Yee Lum, John R. Thompson and Joel P. Berger
      Molecular Pharmacology July 2012, 82 (1) 68-79; DOI: https://doi.org/10.1124/mol.111.076679

X

  1. Xie, Jing-dun

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

Y

  1. Yu, Qing

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354

Z

  1. Zaharenko, André J.

    1. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of KV Channels
      Steve Peigneur, Diego J. B. Orts, Alvaro R. Prieto da Silva, Nancy Oguiura, Malvina Boni-Mitake, Eduardo B. de Oliveira, André J. Zaharenko, Jose C. de Freitas and Jan Tytgat
      Molecular Pharmacology July 2012, 82 (1) 90-96; DOI: https://doi.org/10.1124/mol.112.078188

  2. Zhang, Xu

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  3. Zhao, Xiao-qin

    1. Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo
      Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, Hong May Sim, Xu Zhang, Yong-ju Liang, Satyakam Singh, Tanaji T. Talele, Yueli Sun, Suresh V. Ambudkar, Zhe-Sheng Chen and Li-wu Fu
      Molecular Pharmacology July 2012, 82 (1) 47-58; DOI: https://doi.org/10.1124/mol.111.076299

  4. Zhorov, Boris S.

    1. Architecture and Pore Block of Eukaryotic Voltage-Gated Sodium Channels in View of NavAb Bacterial Sodium Channel Structure
      Denis B. Tikhonov and Boris S. Zhorov
      Molecular Pharmacology July 2012, 82 (1) 97-104; DOI: https://doi.org/10.1124/mol.112.078212

  5. Zhu, Tongbo

    1. Muscarinic Type 3 Receptor Induces Cytoprotective Signaling in Salivary Gland Cells through Epidermal Growth Factor Receptor Transactivation
      Mikihito Kajiya, Isao Ichimonji, Christine Min, Tongbo Zhu, Jun-O Jin, Qing Yu, Soulafa A. Almazrooa, Seunghee Cha and Toshihisa Kawai
      Molecular Pharmacology July 2012, 82 (1) 115-124; DOI: https://doi.org/10.1124/mol.111.077354
Back to top

In this issue